Molecular diagnostics in South Africa and challenges in the establishment of a molecular laboratory in developing countries

Authors

  • Ashika Singh-Moodley Centre for Healthcare-associated Infections, Antimicrobial Resistance and Mycoses, National Institute for Communicable Diseases, Johannesburg, South Africa
  • Husna Ismail Centre for Healthcare-associated Infections, Antimicrobial Resistance and Mycoses, National Institute for Communicable Diseases, Johannesburg, South Africa
  • Olga Perovic Centre for Healthcare-associated Infections, Antimicrobial Resistance and Mycoses, National Institute for Communicable Diseases, Johannesburg, South Africa

DOI:

https://doi.org/10.3855/jidc.11779

Keywords:

Molecular diagnostics, surveillance, outbreak investigations, laboratory establishment

Abstract

The laboratory plays a significant role in public health surveillance, outbreak investigation and infection prevention and control strategies. Microbiology laboratories are moving towards incorporating molecular biology techniques for the surveillance and identification of pathogens causing infectious diseases as well as the genotypic characterisation of these organisms. These methods are accurate, rapid, reliable, and provide a wealth of information that are not available using conventional phenotypic methods. However, establishing such a laboratory can be challenging in developing countries due to poor infrastructure, the lack of funding and the required expertise. This manuscript discusses the essential issues that need to be addressed when establishing a molecular microbiology laboratory and the usefulness of molecular techniques in public health surveillance and outbreaks in developing countries. Molecular data on South African findings obtained from surveillance and outbreak studies are also presented in this manuscript.

Downloads

Published

2020-03-31

How to Cite

1.
Singh-Moodley A, Ismail H, Perovic O (2020) Molecular diagnostics in South Africa and challenges in the establishment of a molecular laboratory in developing countries. J Infect Dev Ctries 14:236–243. doi: 10.3855/jidc.11779

Issue

Section

Reviews